A Phase 3, Randomized, Placebo‐Controlled Evaluation of the Safety of Intravenous Meloxicam Following Major Surgery

An intravenous (IV) formulation of meloxicam is being studied for moderate to severe pain management. This phase 3, randomized, multicenter, double‐blind, placebo‐controlled trial evaluated the safety of once‐daily meloxicam IV 30 mg in subjects following major elective surgery. Eligible subjects we...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Pharmacol Drug Dev
Main Authors: Bergese, Sergio D., Melson, Timothy I., Candiotti, Keith A., Ayad, Sabry S., Mack, Randall J., McCallum, Stewart W., Du, Wei, Gomez, Alexis, Marcet, Jorge E.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899482/
https://ncbi.nlm.nih.gov/pubmed/30786162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.666
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados